Expert Review of Anti-Infective Therapy

Article	Citations
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition	149
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence	70
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	55
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	51
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	50
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	49
Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis	46
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	44
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan	39
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	39
Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation	38
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	37
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	37
Genetic heterogeneity of group A rotaviruses: a review of the evolutionary dynamics and implication on vaccination	33
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice	31
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?	31
Is the world crippled by antimicrobial resistance, or simply lacking information?	31
Computational analysis of target genes in monkeypox virus infection and potential therapeutic precursors	29
Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)	28
Identification of antibiotic consumption targets for the management of Clostridioides difficile infection in hospitals- a threshold logistic modelling approach	28
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	27
Health literacy, knowledge, household disposal, and misuse practices of antibiotics among UAE residents: a nationwide cross-sectional study	27
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	27
Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs	26
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	26

The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-19	23
Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis	22
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	22
Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience	21
Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease	21
How can we tackle the overuse of antibiotics in low- and middle-income countries?	20
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	20
Neonatal ocular prophylaxis in the United States: is it still necessary?	20
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	19
Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens	18
Visceral leishmaniasis elimination in India: progress and the road ahead	18
Understanding the genetic basis of immune responses to fungal infection	18
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age	17
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China	17
Monoclonal antibodies for the treatment of COVID-19 infection in children	16
Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis	15
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	15
Old biomarkers in tuberculosis management: are they still useful? a systematic review	15
Molecular detections of coronavirus: current and emerging methodologies	14
Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China	14
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	14
Biosimilars as antivirals: opportunities and challenges	14
New advances in the treatments of drug-resistant tuberculosis	14
Clostridioides difficile infection in inflammatory bowel disease: a clinical review	13
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	13
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	13
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	12
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	12
The antifungal pipeline for invasive fungal diseases: what does the future hold?	12
Strategies to improve the diagnosis and clinical treatment of dermatophyte infections	12
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits	12
Improving management of febrile neutropenia in oncology patients: the role of artificial intelligence and machine learning	12
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	12
Therapeutic drug monitoring (TDM) in real-time: a need for the present future	11
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	11
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	11
Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications	11
Therapeutic strategies to address monkeypox	11
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	11
Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study	11
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	11
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy	11
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	10
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs	10
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	10
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects	10
Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis	10
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	10
The value of infectious disease modeling and trend assessment: a public health perspective	10
Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections	10

Alternative drugs for the treatment of gonococcal infections: old and new	9
Evaluation of truenat assays for the diagnosis of pulmonary and extrapulmonary tuberculosis: a systematic review and meta-analysis	9
Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial	9
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	9
Evaluating diagnostic tools, outcome measures and antibiotic approach in diabetic foot osteomyelitis: a scoping review and narrative synthesis	9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	9
Analysis of antimicrobial drug usage in psychiatric specialized hospitals during the pandemic in China	9
Potential activity of nanomaterials to combat SARS-CoV-2 and mucormycosis ‎coinfection‎	9
Overcoming challenges in the management of recurrent urinary tract infections	9
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	9
Reviewing novel treatment options for carbapenem-resistant Enterobacterales	8
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	8
Langya henipavirus outbreak	8
An assessment of the index of rational drug prescribing for severe acute respiratory infections among hospitalised children in Northern Nigeria: a retrospective study	8
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin	8
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice	8
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	8
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	8
Waking up to the Naegleria threat: urgent measures needed to protect public health in Pakistan	8
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?	8
Outpatient treatment options to address the SARS-CoV-2 variant Omicron	8
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?	8
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	7
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations	7
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?	7
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	7
Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis	7
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	7
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability	7
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	7
How do we best manage Clostridioides difficle infections in the elderly?	7
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study	7
How do we change our approach to COVID with the changing face of disease?	7
The circadian rhythm of viruses and its implications on susceptibility to infection	7
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	7
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)	7
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	7
Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events	7
Use of adjuvants to improve antibiotic efficacy and reduce the burden of antimicrobial resistance	6
Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials	6
System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India	6
New insights into the treatment of acute otitis media	6
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	6
Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation	6
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	6
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	6
Gram-negative blood stream infections: prospects and challenges of rapid antimicrobial susceptibility testing	6
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	6
Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients	6
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	6
The rise of mucormycosis in Covid-19 patients in India	6
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	6
Statin use and impact on tuberculosis risk	6
Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box	6
Effect of adalimumab interventions on general infection among adults: a systematic review and meta-analysis of randomized controlled trials	6
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	6
COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention	6
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	6
Brain-eating amoebae: is killing the parasite our only option to prevent death?	5
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection	5
Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment	5
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities	5
Practical diagnostic algorithms for Chagas disease: a focus on low resource settings	5
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	5
Phage therapy in pediatrics: the way forward for difficult-to-treat infections?	5
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	5
Candida auris biofilm: a review on model to mechanism conservation	5
From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B	5
Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies	5
Tocilizumab for the treatment of COVID-19	5
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	5
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	5
Single ascending dose safety, tolerability, and pharmacokinetic study of econazole in healthy volunteers	5
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)	5
Now that griseofulvin is not available, what to do with tinea capitis treatments?	5
Vitamin D receptor gene polymorphism and vitamin D supplementation on clinical/ treatment outcome in tuberculosis: current and future perspectives	5
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	5
Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex spe	5
Lactic acid bacteria: prominent player in the fight against human pathogens	5
Omadacycline in treating community-based infections: a review and expert perspective	4

Classification for β-lactamases: historical perspectives	4
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19	4
Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads	4
Treatment of vaginitis caused by non-albicans Candida species	4
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	4
The effects of the pandemic in cases of heart failure	4
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria	4
Clostridioides difficile infection: an emerging zoonosis?	4
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	4
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review	4
Ethical challenges of prospective clinical trials during the COVID-19 pandemic	4
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	4
Infection-related stillbirth: an update on current knowledge and strategies for prevention	4
Mortality associated with third generation cephalosporin-resistance in Enterobacteriaceae infections: a multicenter cohort study in Southern China	4
IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients	4
The rationale for including osteopathic manipulative treatment in the management of infections: a hermeneutic review	4
Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	4
Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey	4
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	4
Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	4
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	4
The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19	4
Associations of infection control measures and norovirus outbreak outcomes in healthcare settings: a systematic review and meta-analysis	4
Practical use of fecal microbiota spores, live-brpk (formerly SER-109): an oral therapeutic for the prevention of recurrent Clostridioides difficile infection	4
Novel treatment dynamics for biofilm-related infections	3
Efficacy and safety of the all-oral bedaquiline-containing regimen as treatment for pediatric multidrug/rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study	3
Reemergence of monkeypox: prevention and management	3
Treating urinary tract infections in the era of antibiotic resistance	3
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	3
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	3
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	3
Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications	3
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	3
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials	3
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	3
Scrub typhus and antibiotic-resistant Orientia tsutsugamushi	3
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	3
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance	3
Phenotypic, genotypic, and metabolic resistance mechanisms of ESKAPE bacteria to chemical disinfectants: a systematic review and meta-analysis	3
Drug Inspector as an antibiotic steward: challenges and recommendations to implement national action plan of Pakistan on antimicrobial resistance	3
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	3
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	3
Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis	3
Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies	3
Applications of β-defensins against infectious pathogenic microorganisms	3
Anti-MRSA quinolones for acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	3
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	3
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	3
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	3
Artificial intelligence and prescription of antibiotic therapy: present and future	3
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	3
Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line Helicobacter pylori eradication: a real-world evidence study	3
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	3
Prevention and treatment of burn wound infections: the role of topical antimicrobials	3
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	3
Long-term impact of COVID-19 pandemic on antibiotic use in primary care: lessons to optimize antimicrobial use	2
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	2
Treatment options for neonatal infections in the post-cefotaxime era	2
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria	2
The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy	2
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: Expert opinion based on literature and real-life experiences	2
Strengths and caveats of identifying resistance genes from whole genome sequencing data	2
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	2
Fighting with brain-eating amoeba: challenges and new insights to open a road for the treatment of Naegleria fowleri infection	2
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities	2
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study	2
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	2
Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	2
Where does RBX2660 fit within clinical practice?	2
How is ceftobiprole used in Canada: the CLEAR study final results	2
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	2
Lifestyle and rehabilitation during the COVID-19 pandemic: guidance for health professionals and support for exercise and rehabilitation programs	2
Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials	2
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	2
Diagnostic stewardship based on patient profiles: differential approaches in acute versus chronic infectious syndromes	2
Prevalence of antibiotic self-medication behavior and related factors among children aged 0 to 5 years	2
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	2
Gender trend of monkeypox virus infection	2
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis	2
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	2
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	2
Evaluation of health-related quality of life in patients receiving outpatient parenteral antimicrobial therapy (OPAT) in a UK setting	2
Beyond resistance: assessing sulbactam-durlobactam’s role in today’s clinical landscape	2
Diagnosis, prevention, and treatment of coronavirus disease: a review	2
The antifungal activity of caspofungin in combination with antifungals or non-antifungals against Candida species in vitro and in clinical therapy	2
Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now	2
MazEF toxin–antitoxin systems: their role in Mycobacterium tuberculosis stress response and drug resistance	2
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	2
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	2
Evaluation of Tamarix nilotica Fractions in Combating Candida albicans Infections	2
Dengue vaccine: an update	2
Interventions to improve outcomes in community-acquired pneumonia	2
Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 mill	2
Global importance of new treatment strategies to efforts to control hepatitis B virus	2
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review	2